Syndrome News and Research

RSS

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy has shown that isolated cannabinoids or those in hemp extracts have the potential to prevent and treat the infection with the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) – primarily by blocking viral cell entry.

13 Jan 2022

A clinical tool for monoclonal antibody allocation to treat COVID-19

In this research paper, a group of Mayo Clinic researchers discusses how data from MATRx's clinical prioritizing algorithms can be used to address anti-spike monoclonal antibody allocation during times of scarcity.

13 Jan 2022

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

Recently, the researchers from the USA, in their study published in the journal EBioMedicine, have conducted a sequence identity comparison and 3D protein structure comparison between the SARS-CoV-2 spike protein-derived peptides/protein and myocarditis-associated antigens and have found no significant enrichment in the frequency of spike-derived peptides similar to myocarditis-associated antigens that could have resulted in adaptive autoimmune responses leading to myocarditis.

12 Jan 2022

How did the COVID pandemic affect the spread of other zoonotic diseases?

In new research, scientists from the Beijing University of Technology have been investigating the impact of the COVID-19 pandemic on the incidence and mortality of zoonotic diseases in China. Their work is published in the journal BMJ Global Health.

12 Jan 2022

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

Researchers examine the effects of disease-modifying therapies implemented for treating multiple sclerosis on the immune response to SARS-CoV-2 infection.

12 Jan 2022

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

Researchers observe an increase in PEG antibodies following vaccination with the SARS-CoV-2 mRNA lipid nanoparticle vaccine.

12 Jan 2022

How much protection does SARS-CoV-2 infection provide against reinfection?

Researchers determine whether previous SARS-CoV-2 infection protects from reinfection.

12 Jan 2022

High SARS-CoV-2 seroprevalence among captive white-tailed deer in Texas

Researchers investigate the SARS-CoV-2 exposure and infection status of captive white-tailed deer in Texas.

12 Jan 2022

Estimating transmission advantage of SARS-CoV-2 Omicron over Delta in the UK

Researchers estimate daily growth rates for the SARS-CoV-2 Omicron and Delta variants in each UKHSA region of England.

12 Jan 2022

Dynamics of hospital-acquired SARS-CoV-2 infection in a geriatric setting

Researchers investigated the extent of nosocomial SARS-CoV-2 infection among elderly patients and healthcare workers in a geriatric hospital.

12 Jan 2022

Metabolic syndrome linked to worse hospitalization and mortality in COVID-19 patients

Patients with metabolic syndrome have significantly worse hospitalization and mortality rates due to COVID-19.

12 Jan 2022

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

A new study used target trial emulation design for comparison of both the vaccines in the VA healthcare system against the risk of infection, hospitalization, and death from COVID-19.

12 Jan 2022

Airborne decay of SARS-CoV-2 occurs within minutes

A new study, posted to the medRxiv* preprint server, has focused on the survival of SARS-CoV-2 in airborne droplets of cell culture medium.

11 Jan 2022

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

A new study from the United States (US) investigates the persistence (lifetime) of viral ribonucleic acid (RNA) under different ambient conditions within wastewater infrastructure to understand how it impacts RNA measurements and the related wastewater epidemiology.

11 Jan 2022

A common cold may boost the immune system against COVID-19

A recent groundbreaking research paper published in the journal Nature Communications reveals the association of circulating SARS-CoV-2-specific T cells at exposure with lack of infection – implying the protective role for cross-reactive immune T cells in coronavirus disease 2019 (COVID-19) and opening the door for second-generation vaccines that could circumvent spike-antibody immune escape variants.

11 Jan 2022

Danish household study shows COVID vaccinates reduce susceptibility and transmissibility

A new study discusses the effect of vaccines against COVID-19 on the transmissibility and susceptibility of vaccine recipients to SARS-CoV-2.

11 Jan 2022

Engineering higher affinity SARS-CoV-2 antibodies

A new study describes the potential of engineered neutralizing antibodies that have a high affinity for the binding epitopes.

11 Jan 2022

Study opens up prospects for using virotherapy to treat central nervous system tumors

In a study conducted at the University of São Paulo's Human Genome and Stem Cell Research Center (HUG-CELL) in Brazil, serial systemic injections of zika virus into mice with brain tumors destroyed the cancer without causing neurological damage or injuring other organs, and increased the animals' survival rate.

11 Jan 2022

Third dose of mRNA COVID vaccine induces strong immunity in older adults

A new study describes the beneficial effects of a third dose of the COVID-19 mRNA vaccine in strengthening immunity among older adults.

11 Jan 2022

Novel mechanism linking intercellular adhesion molecule with genetic skin diseases discovered

Northwestern Medicine investigators have discovered a novel mechanism linking an intercellular adhesion molecule with genetic inflammatory skin diseases, according to findings published in the Journal of Clinical Investigation.

11 Jan 2022

Syndrome News and Research

Cannabinoids may prevent infection with SARS-CoV-2, including variants

A clinical tool for monoclonal antibody allocation to treat COVID-19

Lack of evidence cross-reactive adaptive immune response is mechanism underlying COVID vaccine-induced myocarditis

How did the COVID pandemic affect the spread of other zoonotic diseases?

Cellular and humoral response to SARS-CoV-2 in multiple sclerosis patients using disease-modifying therapies

The impact of Comirnaty vaccination on the levels of PEG specific antibodies

How much protection does SARS-CoV-2 infection provide against reinfection?

High SARS-CoV-2 seroprevalence among captive white-tailed deer in Texas

Estimating transmission advantage of SARS-CoV-2 Omicron over Delta in the UK

Dynamics of hospital-acquired SARS-CoV-2 infection in a geriatric setting

Metabolic syndrome linked to worse hospitalization and mortality in COVID-19 patients

Comparing the Moderna and Pfizer-Biontech vaccines against SARS-CoV-2 infection

Airborne decay of SARS-CoV-2 occurs within minutes

SARS-CoV-2 and pepper mild mottle virus RNA highly persistent in wastewater solids

A common cold may boost the immune system against COVID-19

Danish household study shows COVID vaccinates reduce susceptibility and transmissibility

Engineering higher affinity SARS-CoV-2 antibodies

Study opens up prospects for using virotherapy to treat central nervous system tumors

Third dose of mRNA COVID vaccine induces strong immunity in older adults

Novel mechanism linking intercellular adhesion molecule with genetic skin diseases discovered

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News